Steven Leonard Chapman - 20 Jan 2026 Form 4 Insider Report for Natera, Inc. (NTRA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Jan 2026, 21:35:07 UTC
Prior SEC filing
16 Jan 2026
Next SEC filing
29 Jan 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tami Chen, Attorney-in-Fact

Key filing fact

Steven Leonard Chapman filed Form 4 for Natera, Inc. (NTRA) on 22 Jan 2026.

Key facts

  • This page summarizes Steven Leonard Chapman's Form 4 filing for Natera, Inc. (NTRA).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 22 Jan 2026, 21:35.

Change

  • Previous filing in this sequence was filed on 16 Jan 2026.
  • Current net transaction value: -$17,258,853.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001711968 Primary reporting owner

Chapman Steven Leonard

Relationship
CEO AND PRESIDENT, Director
Address
C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN
Signature
/s/ Tami Chen, Attorney-in-Fact
Signature date
22 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTRA transaction

Common Stock

Sale

Transaction value
$16,885,203
Shares
-71,932
Change %
-25%
Price
$234.74
Shares after
217,354
Date
20 Jan 2026
Ownership
Direct
Footnotes
F1
NTRA transaction

Common Stock

Options Exercise

Transaction value
Shares
+3,386
Change %
+1.6%
Price
Shares after
220,740
Date
20 Jan 2026
Ownership
Direct
Footnotes
F2
NTRA transaction

Common Stock

Sale

Transaction value
$373,650
Shares
-1,590
Change %
-0.72%
Price
$235.00
Shares after
219,150
Date
21 Jan 2026
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NTRA transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-3,386
Change %
-100%
Price
$0.000000
Shares after
0
Date
20 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,386
Exercise price
Footnotes
F2, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs) and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.

Footnote F2

Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F3

The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 28, 2022.

Footnote F4

The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .